13F Pro13F Pro

Privium Fund Management B.V.

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1795097
Institutional-grade research for retail investors

Sector Allocation

  • Healthcare32.6%$177.6M
  • Technology25.4%$138.0M
  • Consumer Discretionary23.9%$130.0M
  • Communication Services7.0%$38.1M
  • Financials6.2%$33.7M
  • Real Estate3.4%$18.2M
  • Consumer Staples0.7%$4.0M
  • Energy0.5%$2.8M
  • Materials0.2%$1.2M
  • Industrials0.1%$578,548

AUM History

13fpro.ai/research/fund/privium-fund-management-b-v-1795097

Conviction and streaks

Diversifying · top 10 = 61.8%

From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.

TSLA$TSLAConviction hold17.6% weight · held 10 quartersSHOP$SHOPConviction hold7.8% weight · held 10 quartersAMD$AMDConviction hold6.6% weight · held 4 quartersAMZN$AMZNConviction hold6.1% weight · held 10 quartersIONS$IONSConviction hold4.7% weight · held 10 quartersPRQR$PRQRAccumulating+11% shares · 5 quarters runningLMND$LMNDAccumulating+86% shares · 3 quarters runningIREN$IRENAccumulating+162% shares · 3 quarters runningSRPT$SRPTAccumulating+246% shares · 3 quarters runningTSHA$TSHAAccumulating+47% shares · 3 quarters runningSPOT$SPOTTrimming-62% shares · 5 quarters runningARWR$ARWRTrimming-63% shares · 5 quarters runningSHOP$SHOPTrimming-14% shares · 4 quarters runningABEV$ABEVTrimming-25% shares · 2 quarters runningFDMT$FDMTTrimming-57% shares · 2 quarters running

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/privium-fund-management-b-v-1795097

Privium Fund Management B.V. 13F holdings — Q2 2026

$544.2M portfolio (+13.3% QoQ) · 61 holdings · Q2 2026 13F · top 10 are 62% of the stock portfolio

All holdings — Privium Fund Management B.V. (Q2 2026)

61 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
NVDA$NVDANVIDIA CORP$16.2M—
IREN$IRENIREN Ltd$15.6M+6%
QURE$QUREuniQure N.V.$15.1M-33%
CBRS$CBRSCerebras Systems Inc.$13.4MNew
ASTS$ASTSAST SpaceMobile, Inc.$12.9M—
RARE$RAREUltragenyx Pharmaceutical Inc.$11.3M-7%
ARQT$ARQTArcutis Biotherapeutics, Inc.$10.5M+24%
BIIB$BIIBBIOGEN INC.$10.5M+11%
PRQR$PRQRProQR Therapeutics N.V.$10.3M+1.0%
AXSM$AXSMAxsome Therapeutics, Inc.$9.8M-32%
URGN$URGNUroGen Pharma Ltd.$7.7M-12%
SPCX$SPCXSPACE EXPLORATION TECHNOLOGIES CORP$6.8MNew
DNLI$DNLIDenali Therapeutics Inc.$5.9M-10%
VRTX$VRTXVERTEX PHARMACEUTICALS INC / MA$4.7M-17%
BMRN$BMRNBIOMARIN PHARMACEUTICAL INC$4.3M-19%

What changed in Q2 2026

Against the previous quarter's 13F: 10 new, 18 added to, 20 trimmed, 9 sold out. Share-count changes; largest moves by dollar size first.

New positions (10)

  • OPEN$OPENOpendoor Technologies Inc.$18.2M

    first bought this quarter

  • CBRS$CBRSCerebras Systems Inc.$13.4M

    first bought this quarter

  • SPCX$SPCXSPACE EXPLORATION TECHNOLOGIES CORP$6.8M

    first bought this quarter

  • MICC$MICCMagnum Ice Cream Co N.V.$1.5M

    first bought this quarter

  • ZTS$ZTSZoetis Inc.$1.2M

    first bought this quarter

  • LEGN$LEGNLegend Biotech Corp$1.0M

    first bought this quarter

+4 more in the Excel export

Added to (18)

  • AMZN$AMZNAMAZON COM INC+12%

    now $33.4M · held 11+ qtrs, 2 adds in a row

  • TSLA$TSLATesla, Inc.+3%

    now $95.9M · held 11+ qtrs

  • IONS$IONSIONIS PHARMACEUTICALS INC+10%

    now $25.4M · held 11+ qtrs, 2 adds in a row

  • ARQT$ARQTArcutis Biotherapeutics, Inc.+24%

    now $10.5M · held 7 qtrs, 2 adds in a row

  • SRPT$SRPTSarepta Therapeutics, Inc.+197%

    now $2.5M · held 3 qtrs, 3 adds in a row

  • HIMS$HIMSHims & Hers Health, Inc.+100%

    now $2.8M · held 5 qtrs

+12 more in the Excel export

Trimmed (20)

  • ARWR$ARWRARROWHEAD PHARMACEUTICALS, INC.-36%

    now $19.1M · held 11+ qtrs, 5 trims in a row

  • QURE$QUREuniQure N.V.-33%

    now $15.1M · held 10 qtrs

  • SPOT$SPOTSpotify Technology S.A.-18%

    now $25.3M · held 10 qtrs, 5 trims in a row

  • AXSM$AXSMAxsome Therapeutics, Inc.-32%

    now $9.8M · held 11+ qtrs

  • SHOP$SHOPSHOPIFY INC.-9%

    now $42.2M · held 11+ qtrs

  • MOH$MOHMOLINA HEALTHCARE, INC.-63%

    now $681K · held 2 qtrs

+14 more in the Excel export

Sold out (9)

  • COIN$COINCoinbase Global, Inc.was $13.8M

    held 4 qtrs

  • SE$SESea Ltdwas $11.4M

    held 9 qtrs

  • ESPR$ESPREsperion Therapeutics, Inc.was $9.0M

    held 1 qtr

  • STOK$STOKStoke Therapeutics, Inc.was $1.6M

    held 2 qtrs

  • PFE$PFEPFIZER INCwas $1.5M
  • SLB$SLBSLB LIMITED/NVwas $948K

+3 more in the Excel export

Share

Holdings by quarter

Every 13F Privium Fund Management B.V. has filed, 18 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow Privium Fund Management B.V.?

Q2 2026 13F filed with the SEC on Aug 7, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of Privium Fund Management B.V.'s top 20 holdings: 55/100 (our AI quality score, weighted by position size; 16 of the 20 are scored)

Top 10 since filing

+2.6%

Value-weighted move of the 10 largest stock positions

Turnover

12%

Last quarter; 33% over the last 4

Top 10 weight

62%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

88%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2023 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

Privium Fund Management B.V. disclosed 61 positions worth $544.2M in its Form 13F-HR for Q2 2026, led by $TSLA (Tesla, Inc.) at 17.6% of the equity portfolio, followed by $SHOP and $AMD. During the quarter the fund opened 10 new positions and exited 9 — including a new stake in $OPEN and a full exit from $COIN. The portfolio is most concentrated in Healthcare (32.6% of disclosed assets). All figures are sourced directly from Privium Fund Management B.V.’s Form 13F-HR filing with the SEC under CIK 1795097.

Funds like this

managers whose biggest positions overlap Privium Fund Management B.V.'s
BAILLIE GIFFORD & CO$110.23B 13F book · 5 shared top holdingsSPOTSHOPSPCXALNYNikko Asset Management Americas, Inc.$7.75B 13F book · 7 shared top holdingsSHOPPLTRSPCXSPOTARK Investment Management LLC$15.40B 13F book · 6 shared top holdingsSHOPPLTRSPCXCBRSEDGEWOOD MANAGEMENT LLC$9.69B 13F book · 3 shared top holdingsSHOPSPOTVRTXSANDS CAPITAL MANAGEMENT, LLC$26.93B 13F book · 3 shared top holdingsSHOPSPOTSPCXAvoro Capital Advisors LLC$11.14B 13F book · 4 shared top holdingsARWRQUREKRYSVRDN

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: Privium Fund Management B.V.

13F Pro is an AI hedge fund tracker and stock research platform. For Privium Fund Management B.V. (SEC CIK: 1795097), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in Privium Fund Management B.V.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.